|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/437 | (2006.01) |
| C07D 471/04 | (2006.01) | ||
| A61P 1/00 | (2006.01) |
| (11) | Number of the document | 3373931 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16865156.0 |
| Date of filing the European patent application | 2016-11-11 | |
| (97) | Date of publication of the European application | 2018-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-28 |
| (46) | Date of publication of the claims translation | 2023-03-10 |
| (86) | Number | PCT/US2016/061676 |
| Date | 2016-11-11 |
| (87) | Number | WO 2017/083756 |
| Date | 2017-05-18 |
| (30) | Number | Date | Country code |
| 201562255041 P | 2015-11-13 | US |
| (72) |
MOHAN, Raju , US
NUSS, John , US
HARRIS, Jason , US
|
| (73) |
Oppilan Pharma Ltd. ,
St. John's Innovation Centre
Cowley Road, Cambridge
CB4 0WS,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Heterocikliniai junginiai skirti ligos gydymui |
| HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE |
| Payment date | Validity (years) | Amount | |
| 2024-10-31 | 9 | 208.00 EUR |
| 2025-11-11 |